Stem (NYSE:STEM – Get Free Report) had its target price lifted by equities researchers at Roth Mkm from $0.35 to $0.40 in a report released on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Roth Mkm’s price objective would indicate a potential downside of 17.01% from the company’s current price.
A number of other research firms also recently weighed in on STEM. Piper Sandler dropped their price target on shares of Stem from $1.50 to $0.30 and set a “neutral” rating on the stock in a research note on Friday, November 22nd. UBS Group dropped their price target on shares of Stem from $1.00 to $0.60 and set a “buy” rating on the stock in a research report on Friday, November 8th. Finally, BMO Capital Markets decreased their price objective on Stem from $0.50 to $0.40 and set a “market perform” rating on the stock in a report on Wednesday. Seven research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $1.11.
Read Our Latest Stock Analysis on Stem
Stem Trading Up 4.8 %
Stem (NYSE:STEM – Get Free Report) last posted its quarterly earnings data on Tuesday, March 4th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.04. The firm had revenue of $55.83 million for the quarter, compared to analysts’ expectations of $47.89 million. Stem had a negative net margin of 328.11% and a negative return on equity of 275.79%. During the same period in the previous year, the company posted ($0.21) EPS. On average, research analysts expect that Stem will post -0.52 EPS for the current year.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the company. Barclays PLC grew its holdings in shares of Stem by 213.1% during the third quarter. Barclays PLC now owns 235,336 shares of the company’s stock valued at $81,000 after buying an additional 160,165 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Stem by 4.8% in the 3rd quarter. Geode Capital Management LLC now owns 3,604,073 shares of the company’s stock worth $1,255,000 after purchasing an additional 166,002 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Stem by 77.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,406,080 shares of the company’s stock worth $837,000 after buying an additional 1,047,825 shares during the last quarter. Creative Planning increased its position in shares of Stem by 177.1% during the third quarter. Creative Planning now owns 123,521 shares of the company’s stock valued at $43,000 after acquiring an additional 78,940 shares in the last quarter. Finally, Aries Wealth Management grew its stake in shares of Stem by 100.0% during the 4th quarter. Aries Wealth Management now owns 50,000 shares of the company’s stock valued at $30,000 after purchasing an additional 25,000 shares during the period. 61.63% of the stock is currently owned by institutional investors.
Stem Company Profile
Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.
Recommended Stories
- Five stocks we like better than Stem
- Short Selling – The Pros and Cons
- Is Advanced Micro Devices Stock Slide Over?
- Business Services Stocks Investing
- Lemonade’s Q4 Surge: Has This AI-Powered Insurer Turned a Corner?
- Find and Profitably Trade Stocks at 52-Week Lows
- 2 Energy Stocks to Play Both Sides of Tariff Uncertainty
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.